You just read:

CorMatrix® Cardiovascular, Inc. receives FDA approval to expand and enroll 20 additional patients in the adult arm of its early feasibility IDE study of the Cor® TRICUSPID ECM® valve for pediatric and adult patients

News provided by

CorMatrix® Cardiovascular, Inc.

Feb 07, 2020, 10:00 ET